ArticleFrontiers in oncology2024

Based on machine learning, CDC20 has been identified as a biomarker for postoperative recurrence and progression in stage I & II lung adenocarcinoma patients.

Rui Miao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.